Solid Biosciences Announces FDA Lifts Clinical Hold on IGNITE DMD Clinical Trial
– Modifications to IGNITE DMD trial protocol and improvements to manufacturing processes enable continued program development –CAMBRIDGE, Mass., Oct. 01, […]
AnPac Bio Announces Equity Investment from Keystone Capital Partners for up to $7 Million
SAN JOSE, Calif., Oct. 01, 2020 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) […]
Edison Nation, Inc. Announces Acquisition of TBD Safety, LLC and its Flagship Product Line 911 Help Now®
BETHLEHEM, Pa., Oct. 01, 2020 (GLOBE NEWSWIRE) — Edison Nation, Inc., a multifaceted ecosystem that fosters innovation and drives IP, […]
BRP Group, Inc. to Seek New Senior Secured Facilities
TAMPA, Fla., Oct. 01, 2020 (GLOBE NEWSWIRE) — BRP Group, Inc. (“BRP Group” or the “Company”) (NASDAQ: BRP), a rapidly […]
VYNE Therapeutics Announces ZILXI™ (minocycline) topical foam, 1.5% is Available in Pharmacies Nationwide Today, October 1st
ZILXI is the First FDA Approved Minocycline Product for the Treatment of Inflammatory Lesions of Rosacea in AdultsZILXI Offers Efficacy […]
Akouos Announces Key Leadership Appointments
BOSTON, Oct. 01, 2020 (GLOBE NEWSWIRE) — Akouos, Inc. (NASDAQ: AKUS), a precision genetic medicine company dedicated to developing potential […]
Cara Therapeutics Appoints Thomas Reilly as Chief Financial Officer
STAMFORD, Conn., Oct. 01, 2020 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing […]
Fulcrum Therapeutics Announces Multiple Presentations During the Virtual 25th International Congress of the World Muscle Society
CAMBRIDGE, Mass., Oct. 01, 2020 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives […]
Silence Therapeutics to Participate in the Chardan Virtual 4th Annual Genetic Medicines Conference
Silence Therapeutics to Participate in the Chardan Virtual 4th Annual Genetic Medicines Conference1 October 2020LONDON, Silence Therapeutics plc (AIM: SLN) […]
Replimune to Participate at the Chardan Virtual 4th Annual Genetic Medicines Conference
WOBURN, Mass., Oct. 01, 2020 (GLOBE NEWSWIRE) — Replimune Group Inc. (Nasdaq: REPL), a biotechnology company developing oncolytic immuno-gene therapies […]
